Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors

BACKGROUND: The immunohistochemical demonstration of Enhancer of zeste homologue 2 (EZH2) proved to be a useful marker in several tumor types. It has been described to distinguish reliably hepatocellular carcinomas from liver adenomas and other benign hepatocellular lesions. However, no other types...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajósi-Kalcakosz, Szofia, Dezső, Katalin, Bugyik, Edina, Bödör, Csaba, Paku, Sándor, Pávai, Zoltán, Halász, Judit, Schlachter, Krisztina, Schaff, Zsuzsa, Nagy, Péter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436720/
https://www.ncbi.nlm.nih.gov/pubmed/22809481
http://dx.doi.org/10.1186/1746-1596-7-86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436720/
https://www.ncbi.nlm.nih.gov/pubmed/22809481
http://dx.doi.org/10.1186/1746-1596-7-86

Ejemplares similares